Professor | Binghao Li | Asia Growth Partners

	Upload Avatar (500 x 500)
Name	Binghao Li
Contact Information	libinghao@zju.edu.cn
Language ability	English, Chinese
Province	Zhejiang

Upload Avatar (500 x 500)

Name

Binghao Li

Contact Information

libinghao@zju.edu.cn

Language ability

English, Chinese

Province

Zhejiang

University/Lab Affiliation and Title	Zhejiang University
Faculty	Medical
Academic Background & Achievements	2015-2017 Ph.D. in Tumor Immunology: Harvard Medical School, Supervisor: Mark C. Poznansky 2012-2017 M.D./Ph.D. in Surgery (Orthopedics): Zhejiang University, Supervisor: Ye Zhaoming 2011-2011 Exchange Student in Clinical Medicine: University of Western Australia, Supervisor: David A. Joyce 2007-2012 Bachelor's in Clinical Medicine: Shanghai Jiao Tong University Zhejiang University 'Outstanding Young Clinical Talent' cultivation target Recipient of Zhejiang Provincial Outstanding Youth Fund

University/Lab Affiliation and Title

Zhejiang University

Faculty

Medical

Academic Background & Achievements

2015-2017 Ph.D. in Tumor Immunology: Harvard Medical School, Supervisor: Mark C. Poznansky
2012-2017 M.D./Ph.D. in Surgery (Orthopedics): Zhejiang University, Supervisor: Ye Zhaoming
2011-2011 Exchange Student in Clinical Medicine: University of Western Australia, Supervisor: David A. Joyce
2007-2012 Bachelor's in Clinical Medicine: Shanghai Jiao Tong University
Zhejiang University 'Outstanding Young Clinical Talent' cultivation target
Recipient of Zhejiang Provincial Outstanding Youth Fund

Areas of Focus	Surgical treatment of bone and soft tissue tumors and bone metastases Immune microenvironment and immunotherapy of bone and soft tissue tumors
Publications	Metabolic control of CD47 expression through LAT2-mediated amino acid uptake promotes tumor immune evasion, Wang Z#, Li B#, Li S#, Lin W, Wang Z, Wang S, Chen W, Shi W, Chen T, Zhou H, Yinwang E, Zhang W, Mou H, Chai X, Zhang J, Lu Z, Ye Z, 2022 Fresh tissue multi-omics profiling reveals immune classification and suggests immunotherapy candidates of conventional chondrosarcoma, Li B#, Li G#, Yan X#, Zhu D, Lin PP, Wang Z, Qu H, He X, Fu Y, Zhu X, Lin P, Zhang J, Li X, Dai H, Chen H, Poznansky MC, Lin N, Ye Z, 2021 Genomic characterization and outcome evaluation of kinome fusions in a large lung cancer population revealed novel druggable fusions, Li B#, Qu H#, Zhang J#, Pan W, Liu M, Yan X, Huang X, He X, Lin D, Liu S, Guan R, Wu Y, Ou Q, Bao H, Xu Y, Wu X, Shao Y, Lin N, 2021 Epigenetic regulation of CXCL12 plays a critical role in mediating tumor progression and the immune response in osteosarcoma, Li B#, Wang Z#, Wu H, Xue M, Lin P, Wang S, Lin N, Huang X, Pan W, Liu M, Yan X, Qu H, Sun L, Li H, Wu Y, Teng W, Wang Z, Zhou X, Chen H, Poznansky MC, Ye Z, 2018 AMD3100 Augments the Efficacy of Mesothelin-Targeted, Immune-Activating VIC-008 in Mesothelioma by Modulating Intratumoral Immunosuppression, Li B#, Zeng Y#, Reeves PM, Ran C, Liu Q, Qu X, Liang Y, Liu Z, Yuan J, Leblanc PR, Ye Z, Sluder AE, Gelfand JA, Brauns TA, Chen H*, Poznansky MC, 2018

Areas of Focus

Surgical treatment of bone and soft tissue tumors and bone metastases
Immune microenvironment and immunotherapy of bone and soft tissue tumors

Publications

Metabolic control of CD47 expression through LAT2-mediated amino acid uptake promotes tumor immune evasion, Wang Z#, Li B#, Li S#, Lin W, Wang Z, Wang S, Chen W, Shi W, Chen T, Zhou H, Yinwang E, Zhang W, Mou H, Chai X, Zhang J, Lu Z, Ye Z*, 2022
Fresh tissue multi-omics profiling reveals immune classification and suggests immunotherapy candidates of conventional chondrosarcoma, Li B#, Li G#, Yan X#, Zhu D, Lin PP, Wang Z, Qu H, He X, Fu Y, Zhu X, Lin P, Zhang J, Li X, Dai H, Chen H, Poznansky MC, Lin N, Ye Z*, 2021
Genomic characterization and outcome evaluation of kinome fusions in a large lung cancer population revealed novel druggable fusions, Li B#, Qu H#, Zhang J#, Pan W, Liu M, Yan X, Huang X, He X, Lin D, Liu S, Guan R, Wu Y, Ou Q, Bao H, Xu Y, Wu X, Shao Y, Lin N*, 2021
Epigenetic regulation of CXCL12 plays a critical role in mediating tumor progression and the immune response in osteosarcoma, Li B#, Wang Z#, Wu H, Xue M, Lin P, Wang S, Lin N, Huang X, Pan W, Liu M, Yan X, Qu H, Sun L, Li H, Wu Y, Teng W, Wang Z, Zhou X, Chen H, Poznansky MC, Ye Z*, 2018
AMD3100 Augments the Efficacy of Mesothelin-Targeted, Immune-Activating VIC-008 in Mesothelioma by Modulating Intratumoral Immunosuppression, Li B#, Zeng Y#, Reeves PM, Ran C, Liu Q, Qu X, Liang Y, Liu Z, Yuan J, Leblanc PR, Ye Z, Sluder AE, Gelfand JA, Brauns TA, Chen H*, Poznansky MC, 2018

Bone Tumors Soft Tissue Tumors Bone Metastases Surgical Treatment Immune Microenvironment Immunotherapy Chemokines Tumor Immunity Chondrosarcoma Clinical Trials

Qi Zhang - Zhejiang University

Xia Dajing - Zhejiang University

Yunhua Liu - Zhejiang University

View All

Personal Information

Academic Information

Research

Contact us

No account yet?

Personal Information

Academic Information

Research

Contact us